{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:44:18Z","timestamp":1763001858412,"version":"3.45.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004206","name":"Osaka University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004206","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.lanwpc.2022.100661","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:03:42Z","timestamp":1671494622000},"page":"100661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in Japan"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8314-9294","authenticated-orcid":false,"given":"Yuta","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-4554","authenticated-orcid":false,"given":"Shinichiro","family":"Nameki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4050-2350","authenticated-orcid":false,"given":"Yasuhiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8732-7310","authenticated-orcid":false,"given":"Ryotaro","family":"Saita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoharu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruaki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Yoshimine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Amiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Okita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7089-3479","authenticated-orcid":false,"given":"Jun","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8451-9501","authenticated-orcid":false,"given":"Akane","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyota","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumiyuki","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2523-2938","authenticated-orcid":false,"given":"Yoshihito","family":"Shima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Narazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kumanogoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2022.100661_bib1","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanwpc.2022.100661_bib2","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1056\/NEJMoa2114114","article-title":"Waning of BNT162b2 vaccine protection against SARS-CoV-2 Infection in Qatar","volume":"385","author":"Chemaitelly","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanwpc.2022.100661_bib3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.lanwpc.2022.100661_bib4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/annrheumdis-2021-221575","article-title":"Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations","volume":"81","author":"Kroon","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lanwpc.2022.100661_bib5","doi-asserted-by":"crossref","first-page":"e724","DOI":"10.1016\/S2665-9913(21)00247-2","article-title":"COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses","volume":"3","author":"Fagni","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.lanwpc.2022.100661_bib6","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1136\/annrheumdis-2021-221824","article-title":"BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study","volume":"81","author":"Bieber","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lanwpc.2022.100661_bib7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/annrheumdis-2021-222045","article-title":"Efficacy of COVID-19 vaccines in patients taking immunosuppressants","volume":"81","author":"Shen","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lanwpc.2022.100661_bib8","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/annrheumdis-2021-220647","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study","volume":"80","author":"Furer","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lanwpc.2022.100661_bib9","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/annrheumdis-2021-221508","article-title":"Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases","volume":"81","author":"Hadjadj","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lanwpc.2022.100661_bib10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2021-221735","article-title":"Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis","volume":"81","author":"Medeiros-Ribeiro","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lanwpc.2022.100661_bib11","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanwpc.2022.100661_bib12","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/annrheumdis-2021-221554","article-title":"Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease","volume":"81","author":"Simon","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lanwpc.2022.100661_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.lanwpc.2022.100661_bib14","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4049\/jimmunol.180.2.688","article-title":"Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks","volume":"180","author":"Anolik","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.lanwpc.2022.100661_bib15","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.clinthera.2018.04.016","article-title":"B\u00a0lymphocytes in rheumatoid arthritis and the effects of anti\u2013TNF-\u03b1 agents on B lymphocytes: a review of the literature","volume":"40","author":"Pala","year":"2018","journal-title":"Clin Ther"},{"key":"10.1016\/j.lanwpc.2022.100661_bib16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.2007.077552","article-title":"The effect of anti-tumour necrosis factor \u03b1 treatment on the antibody response to influenza vaccination","volume":"67","author":"Gelinck","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lanwpc.2022.100661_bib17","doi-asserted-by":"crossref","first-page":"R209","DOI":"10.1186\/ar3542","article-title":"Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor","volume":"13","author":"Kobie","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lanwpc.2022.100661_bib18","first-page":"1327","article-title":"Reduced antibody activity against SARS-CoV-2 B.1.617.2 Delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-\u03b1 inhibitors","volume":"2","author":"Chen","year":"2021","journal-title":"Med (N Y)"},{"key":"10.1016\/j.lanwpc.2022.100661_bib19","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1016\/S2665-9913(22)00069-8","article-title":"Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease","volume":"4","author":"Haberman","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.lanwpc.2022.100661_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1586\/1744666X.2016.1133295","article-title":"CTLA-4 blockade in the treatment of rheumatoid arthritis: an update","volume":"12","author":"Cutolo","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.lanwpc.2022.100661_bib21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.14.1.591","article-title":"Immune regulation by CD40 and its ligand GP39","volume":"14","author":"Foy","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.lanwpc.2022.100661_bib22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3899\/jrheum.130905","article-title":"Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritis","volume":"41","author":"Scarsi","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.lanwpc.2022.100661_bib23","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.4049\/jimmunol.0803783","article-title":"B7-1\/2 (CD80\/CD86) direct signaling to B cells enhances IgG secretion","volume":"183","author":"Rau","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.lanwpc.2022.100661_bib24","doi-asserted-by":"crossref","first-page":"R171","DOI":"10.1186\/ar4358","article-title":"Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis","volume":"15","author":"Crnkic Kapetanovic","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lanwpc.2022.100661_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/acr.21838","article-title":"Abatacept and reduced immune response to pandemic 2009 influenza A\/H1N1 vaccination in patients with rheumatoid arthritis","volume":"65","author":"Ribeiro","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.lanwpc.2022.100661_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002050","article-title":"Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses","volume":"8","author":"Saleem","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.lanwpc.2022.100661_bib27","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1111\/ajt.16814","article-title":"Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept","volume":"21","author":"Chavarot","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.lanwpc.2022.100661_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamainternmed.2021.7372","article-title":"Comparison of SARS-CoV-2 antibody response 4 weeks after homologous vs heterologous third vaccine dose in kidney transplant recipients","volume":"182","author":"Reindl-Schwaighofer","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.lanwpc.2022.100661_bib29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","article-title":"T\u00a0cell responses to SARS-CoV-2 spike cross-recognize Omicron","volume":"603","author":"Keeton","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.lanwpc.2022.100661_bib30","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0168-8278(22)00518-9","article-title":"T\u00a0cell and humoral immune\u00a0response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients\u00a0with cirrhosis and liver diseases requiring immunosuppression: data from the EASL COVID-Hep network","volume":"77","author":"Murray","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.lanwpc.2022.100661_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2022-222954","article-title":"Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave","volume":"81","author":"Kawano","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lanwpc.2022.100661_bib32","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/ajt.17054","article-title":"Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529\u00a0(omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients","volume":"22","author":"Benning","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.lanwpc.2022.100661_bib33","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S2213-2600(21)00220-4","article-title":"BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers","volume":"9","author":"Lustig","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.lanwpc.2022.100661_bib34","doi-asserted-by":"crossref","first-page":"1861.e1","DOI":"10.1016\/j.cmi.2021.07.042","article-title":"Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan","volume":"27","author":"Kageyama","year":"2021","journal-title":"Clin Microbiol Infect"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606522002760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606522002760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:40:40Z","timestamp":1763001640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606522002760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":34,"alternative-id":["S2666606522002760"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100661","relation":{},"ISSN":["2666-6065"],"issn-type":[{"type":"print","value":"2666-6065"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in Japan","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100661"}}